Khosro Hekmat

University of Cologne

Papers

2

Total Citations

39

H-Index

2

About

Dr. Khosro Hekmat is a clinician-researcher whose work bridges the frontiers of thoracic oncology and neuromuscular surgery. His primary research focuses on the application of advanced radiation techniques for lung cancer and the surgical management of myasthenia gravis. Dr. Hekmat’s most impactful contribution is his 2017 study on risk-adapted robotic stereotactic body radiation therapy (SBRT) for inoperable early-stage non-small-cell lung cancer, which has garnered 36 citations. This work is notable for demonstrating how personalized, robotic-guided radiation can achieve high tumor control while minimizing toxicity in fragile patients—a critical advance for those who cannot undergo traditional surgery. In parallel, Dr. Hekmat has tackled the controversial role of thymectomy in non-thymomatous myasthenia gravis. His 2021 review, though early in its citation life, addresses the challenges of low disease incidence and inconsistent long-term follow-up, providing a nuanced analysis of surgical outcomes. By integrating precision radiotherapy with evidence-based surgical decision-making, Dr. Hekmat’s research directly improves treatment paradigms for two challenging patient populations, offering both immediate clinical guidance and a foundation for future prospective trials.

Research Focus

Key Achievements

2
H-Index
2
Papers
39
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer
36 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: University of Cologne

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago